252 related articles for article (PubMed ID: 34958505)
21. Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review.
Kohashi K; Kinoshita I; Oda Y
Head Neck Pathol; 2020 Mar; 14(1):12-20. PubMed ID: 31950473
[TBL] [Abstract][Full Text] [Related]
22. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
[TBL] [Abstract][Full Text] [Related]
23. Correspondence re: Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 2001;14:506-14.
Parham DM
Mod Pathol; 2001 Oct; 14(10):1068. PubMed ID: 11598179
[No Abstract] [Full Text] [Related]
24. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
[TBL] [Abstract][Full Text] [Related]
25. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
Rekhi B; Dodd L; Dharavath B; Dutt A
Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
[TBL] [Abstract][Full Text] [Related]
27. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.
Chen B; Dias P; Jenkins JJ; Savell VH; Parham DM
Am J Pathol; 1998 Apr; 152(4):1071-9. PubMed ID: 9546368
[TBL] [Abstract][Full Text] [Related]
28. Adult sclerosing rhabdomyosarcoma: cytogenetic link with embryonal rhabdomyosarcoma.
Croes R; Debiec-Rychter M; Cokelaere K; De Vos R; Hagemeijer A; Sciot R
Virchows Arch; 2005 Jan; 446(1):64-7. PubMed ID: 15660283
[TBL] [Abstract][Full Text] [Related]
29. Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.
Selfe J; Olmos D; Al-Saadi R; Thway K; Chisholm J; Kelsey A; Shipley J
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035744
[TBL] [Abstract][Full Text] [Related]
30. Rhabdomyosarcoma with epithelioid morphology: A challenging cytologic diagnosis in a pleural effusion.
Rodgers S; Datta L; Perry KD; Stone CH
Diagn Cytopathol; 2021 Sep; 49(9):E356-E359. PubMed ID: 34004052
[TBL] [Abstract][Full Text] [Related]
31. Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Ahn EH; Mercado GE; Laé M; Ladanyi M
Oncol Rep; 2013 Aug; 30(2):968-78. PubMed ID: 23733015
[TBL] [Abstract][Full Text] [Related]
32. Rhabdomyosarcomas in adults and children: an update.
Parham DM; Ellison DA
Arch Pathol Lab Med; 2006 Oct; 130(10):1454-65. PubMed ID: 17090187
[TBL] [Abstract][Full Text] [Related]
33. Pleomorphic rhabdomyosarcoma in children: four cases in the pediatric age group.
Furlong MA; Fanburg-Smith JC
Ann Diagn Pathol; 2001 Aug; 5(4):199-206. PubMed ID: 11510002
[TBL] [Abstract][Full Text] [Related]
34. Intergroup Rhabdomyosarcoma Study: update for pathologists.
Qualman SJ; Coffin CM; Newton WA; Hojo H; Triche TJ; Parham DM; Crist WM
Pediatr Dev Pathol; 1998; 1(6):550-61. PubMed ID: 9724344
[TBL] [Abstract][Full Text] [Related]
35. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
36. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
Pediatr Dev Pathol; 2005; 8(1):141. PubMed ID: 15803220
[No Abstract] [Full Text] [Related]
37. Classification of rhabdomyosarcoma.
Newton WA
Curr Top Pathol; 1995; 89():241-59. PubMed ID: 7882712
[No Abstract] [Full Text] [Related]
38. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1].
Mestre-Alagarda C; Gómez-Mateo MC; Berenguer-Romero MD; Syonghyun NC; Nieto G; Navarro-Fos S
Rev Esp Patol; 2022; 55(1):57-62. PubMed ID: 34980443
[TBL] [Abstract][Full Text] [Related]
39. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
Rekhi B; Singhvi T
APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
[TBL] [Abstract][Full Text] [Related]
40. Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.
Dehner CA; Geiersbach K; Rowsey R; Murugan P; Broski SM; Meis JM; Rosenberg AE; Folpe AL
Mod Pathol; 2023 Jun; 36(6):100131. PubMed ID: 36966552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
